Akili, a company that makes a video game treatment for ADHD, will sell to Virtual Therapeutics for about $34 million, according to a Wednesday regulatory filing. The two companies will merge into a ...

Co-founder and CEO Eddie Martucci, Ph.D. transitions to role of Board chair; Matt Franklin, president and chief operating officer of Akili, appointed president and chief executive officer BOSTON, ...

It’s been a tough year for makers of prescription digital therapeutics, many of whom have had to drastically cut staff—or even, in the case of Pear Therapeutics, completely shut down—to conserve ...

Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness ...

BOSTON & PALO ALTO, Calif.--(BUSINESS WIRE)--Akili Interactive (“Akili” or the “Company”), a leading digital medicine company developing cognitive treatments through game-changing technologies, has ...

Akili, maker of a video game-like digital therapeutic for children with ADHD, hit the public markets Monday after wrapping up a merger with special-purpose acquisition company Social Capital Suvretta ...

BOSTON-- (BUSINESS WIRE)--Akili Interactive Labs, Inc. (“Akili”), a leading digital medicine company pioneering the development of cognitive treatments through game-changing technologies, today ...

Maker of the first-and-only FDA-cleared prescription video game treatment joins the ranks of Canva, Microsoft, SpaceX, and more BOSTON--(BUSINESS WIRE)-- Akili Interactive Labs, Inc. (“Akili”), a ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...